Harvard University Invites Infectious Disease Expert Dr. Dougbeh Chris Nyan to Speak at Health Conference on Africa

By Our Correspondent

BOSTON, USA – The Harvard University T. H. Chan School of Public Health has invited infectious disease specialist and inventor, Dr. Dougbeh Chris Nyan to speak at its inaugural African Health Conference taking place this weekend in the US City of Boston.

Dr. Nyan, a renowned US-based African infectious diseases expert from Liberia, will be speaking on a panel discussion that will delve into the “Implications for Malaria Eradication in sub-Saharan Africa” and will shed light on the challenges faced by African countries in the control of malaria control as well as diagnostics aspect of the disease.

Malaria continues to be one of the most devastating parasitic diseases that is affecting humans. According the 2022 WHO Report, there were about 247 million cases of malaria in 2021 and the estimated number of malaria deaths stood at 619 000 in 2021. The WHO African Region bore a disproportionately high share of the global malaria burden with 95% of malaria cases and 96% of malaria deaths.

The Harvard University health forum is organized by the Harvard Chan Africa Health Students Forum (AHF) and will bringing together faculty, public health students, and policy makers in the healthcare space across Africa.

The infectious disease expert, Dr. Nyan, is Chief Medical and Scientific Officer of Shufflex Biomed, his start-up company that is developing rapid diagnostic tests for malaria and many other infections.

Dougbeh Nyan is globally acclaimed for inventing the Rapid Multiplex Isothermal Real-Time Amplification Test (the NYAN-TEST) that detects and simultaneously differentiates 3 to 7 infections in less than an hour.

Infectious including Malaria, Ebola, COVID-19, Typhoid, Yellow fever, HIV, Hepatitis viruses, Lassa, and several others can be detected by the NYAN-TEST, a breakthrough technology for which Dr. Nyan has been granted three US Patents by the United States Patent and Trademark Office.

Comments are closed.